Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

Navigating Technology Transfer

Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)

Pall Corporation

Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer

Bristol Myers Squibb

View All Featured Articles

Headline News

Robigo raises Series A led by Leaps by Bayer to advance engineered crop protection biologicals

Novartis’s Cosentyx® receives positive CHMP opinion for treating polymyalgia rheumatica

Bio Techne shareholders approve acquisition by Merck KGaA

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

NIR In-Line Monitoring for Drug Product Continuous Process: From Understanding to Control

Presented by Yang (Angela) Liu
19th January 2016

Beyond Purely Data-Driven Approaches for Efficient Knowledge Management in Process Development

Presented by Moritz von Stosch, PhD, Senior Manager, Technical R&D, GlaxoSmithKline Vaccines Followed by Klaus Mauch, CEO at Insilico Biotechnology AG and Shilpa Nargund Data Scientist and Business Development Manager at Insilico Biotechnology AG
02nd September 2019

Development and Manufacturing of Recombinant Nanoparticle Vaccines

Presented by Atin Tomar, President & CEO, CPL Biologicals Pvt. & Amélie Boulais, Vaccine Platform Marketing Manager, Sartorius Stedim Biotech
12th July 2018

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos